Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,791 | 11,433 | 18,565 | 11,949 | 14,744 |
| Marketable Securities | N/A | 5,933 | 2,017 | N/A | N/A |
| TOTAL | $32,352 | $17,656 | $21,012 | $12,836 | $15,112 |
| Non-Current Assets | |||||
| PPE Net | N/A | 25 | 28 | 32 | 35 |
| Investments And Advances | 22 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 63 | 63 | 64 | 62 | 61 |
| TOTAL | $85 | $88 | $92 | $94 | $96 |
| Total Assets | $32,437 | $17,744 | $21,104 | $12,930 | $15,208 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 878 | 1,115 | 1,666 | 306 | 809 |
| Accrued Expenses | 1,021 | 1,516 | 733 | 869 | 1,052 |
| Other current liabilities | N/A | 350 | N/A | N/A | N/A |
| TOTAL | $2,309 | $2,994 | $2,663 | $1,420 | $2,195 |
| Non-Current Liabilities | |||||
| TOTAL | $14 | $16 | $19 | $22 | $26 |
| Total Liabilities | $2,323 | $3,010 | $2,682 | $1,442 | $2,221 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,473 | 48,473 | 39,548 | 34,757 | 34,742 |
| Common Shares | 48 | 40 | 40 | 35 | 35 |
| Retained earnings | -113,941 | -110,011 | -105,818 | -102,390 | -100,973 |
| Other shareholders' equity | -6,113 | -117 | -132 | -145 | -284 |
| TOTAL | $30,114 | $14,734 | $18,422 | $11,488 | $12,987 |
| Total Liabilities And Equity | $32,437 | $17,744 | $21,104 | $12,930 | $15,208 |